INFUSYSTEM HOLDINGS, INC Business Combination, Acquisition Related Costs
INFUSYSTEM HOLDINGS, INC (INFU) reported Business Combination, Acquisition Related Costs of $200.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2023-03-16
- INFUSYSTEM HOLDINGS, INC business combination, acquisition related costs for the quarter ending 2021-12-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC business combination, acquisition related costs for the quarter ending 2021-09-30 was $100.00K.
- INFUSYSTEM HOLDINGS, INC business combination, acquisition related costs for the quarter ending 2021-06-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC business combination, acquisition related costs for the quarter ending 2021-03-31 was $100.00K.
- INFUSYSTEM HOLDINGS, INC business combination, acquisition related costs for fiscal 2021 was $200.00K.
| Period end | Business Combination, Acquisition Related Costs 3 month | Business Combination, Acquisition Related Costs 6 month | Business Combination, Acquisition Related Costs 9 month | Business Combination, Acquisition Related Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $100.00K derived: sum of 2 quarters · filed 2023-03-16 | $100.00K derived: sum of 3 quarters · filed 2023-03-16 | $200.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $100.00K derived: sum of 2 quarters · filed 2022-11-08 | $200.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $100.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |